Santo, a member of the Polpharma Group, is a leading pharmaceutical company in Kazakhstan, specializing in the development, manufacturing, and distribution of essential medicines. With a legacy over a century, Santo provides high-quality, affordable pharmaceuticals, playing a vital role in the region's healthcare sector through local production and adherence to international quality standards.

Manufacturing and Portfolio

Santo operates a modern manufacturing facility in Shymkent, Kazakhstan, producing diverse pharmaceutical products, including solid dosage forms and sterile injectables. Adhering to Good Manufacturing Practice (GMP) standards, the facility ensures medicine safety and efficacy. Its portfolio covers critical therapeutic areas like cardiology, gastroenterology, and anti-infectives, serving public health needs across Kazakhstan and neighboring countries.

Market Reach and Innovation

A prominent pharmaceutical enterprise, Santo maintains a strong market presence in Kazakhstan and exports to other Central Asian and CIS countries. The company actively engages in research and development, expanding its product pipeline and introducing innovative solutions. Integration within the Polpharma Group provides access to global expertise, supporting continuous improvement and sustainable growth.